Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 18, 2009Clinical Pharmacology & TherapeuticsOpen Access

Addressing the Challenges of the Clinical Application of Pharmacogenetic Testing

View Full Paper
Ask AI
Bookmark
Share

Authors

OION IkediobiUniversity of California, San FranciscoJSJaekyu ShinSeoul National UniversityRNRL NussbaumInvitae (United States)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ikediobi et al. (2009) studied this question.

synapsesocial.com/papers/6a158d43814bf8ec9a4ec12dhttps://doi.org/10.1038/clpt.2009.30
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Delivery of Genomic Medicine for Common Chronic Adult Diseases2008 · 307 citations
  2. 2Racial variability in the UDP-glucuronosyltransferase 1 ( UGT1A1 ) promoter: A balanced polymorphism for regulation of bilirubin metabolism?1998 · 859 citations
  3. 3UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters2007 · 472 citations
  4. 4UGT1A7 and UGT1A9 Polymorphisms Predict Response and Toxicity in Colorectal Cancer Patients Treated with Capecitabine/Irinotecan2005 · 264 citations
  5. 5Genetic Variants in the UDP-glucuronosyltransferase 1A1 Gene Predict the Risk of Severe Neutropenia of Irinotecan2004 · 966 citations